Tian Yuan assisted Beijing Tianxing Medical Technology Co., Ltd. (Stock Short Name: "Tianxing Medical", Stock Code: 01609.HK) in successfully completing its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange on May 5, 2026.

Tianxing Medical focuses on sports medicine solutions, providing treatments for soft tissue injuries such as rotator cuffs, ligaments, and meniscus in shoulder, knee, hip, foot/ankle, elbow, and hand/wrist joints. It also offers comprehensive solutions for sports rehabilitation and prevention. Through a patient-centric R&D strategy, the company has amassed a vast customer base, with products sold to over 3,000 hospitals in Mainland China and exported to more than 50 countries and regions across Europe, the Middle East, and Southeast Asia.

In this listing project for Tianxing Medical, the Tian Yuan team acted as the onshore legal advisor to the joint sponsors, deeply involved throughout the entire listing process. With outstanding professional capabilities and a high-quality, efficient, and rigorous work style, the Tian Yuan team assisted the company in successfully completing this listing, earning high recognition from all parties.

This project was led by Tian Yuan senior partner Liu Yan, and jointly completed by partner Liu Juan, partner Zeng Xiangna, and associates Liu Ai, Shi Xiaoqi, and Zhao Lianguan.